Panobinostat

From WikiMD.org
Jump to navigation Jump to search

Panobinostat

Panobinostat (pronounced pano-bin-o-stat) is a drug used in the treatment of various types of cancer, including multiple myeloma and cutaneous T-cell lymphoma. It is classified as a histone deacetylase inhibitor, which works by blocking the action of enzymes involved in cell division and growth.

Etymology

The name "Panobinostat" is derived from the Greek words "pan", meaning "all", and "binos", meaning "life". The suffix "-stat" is commonly used in drug nomenclature to indicate a substance that inhibits or stops a particular action.

Usage

Panobinostat is used in combination with other medications to treat certain types of cancer. It is usually given after other treatments have failed. The drug is taken orally, usually once every other day.

Side Effects

Common side effects of Panobinostat include fatigue, nausea, diarrhea, and vomiting. More serious side effects can include low blood cell counts, electrolyte imbalances, and heart problems.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski